| The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug M Juarez, A Schcolnik-Cabrera, A Dueñas-Gonzalez American journal of cancer research 8 (2), 317, 2018 | 230 | 2018 |
| Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes A Schcolnik-Cabrera, B Oldak, M Juárez, M Cruz-Rivera, A Flisser, ... Apoptosis 24 (3), 245-255, 2019 | 83 | 2019 |
| Ivermectin as an inhibitor of cancer stem‑like cells G Dominguez‑Gomez, A Chavez‑Blanco, JL Medina‑Franco, ... Molecular medicine reports 17 (2), 3397-3403, 2018 | 71 | 2018 |
| Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug M Juarez, A Schcolnik-Cabrera, G Dominguez-Gomez, A Chavez-Blanco, ... Cancer Chemotherapy and Pharmacology 85, 1153-1163, 2020 | 23 | 2020 |
| TFIIH localization is highly dynamic during zygotic genome activation in Drosophila, and its depletion causes catastrophic mitosis G Cruz-Becerra, S Valerio-Cabrera, M Juárez, A Bucio-Mendez, M Zurita Journal of cell science 131 (9), 2018 | 10 | 2018 |
| The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells A Schcolnik‑Cabrera, A Chavez‑Blanco, G Dominguez‑Gomez, M Juarez, ... Oncology letters 20 (3), 3053-3060, 2020 | 8 | 2020 |
| Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy A Schcolnik-Cabrera, A Chavez-Blanco, G Dominguez-Gomez, M Juarez, ... Scientific reports 11 (1), 5222, 2021 | 7 | 2021 |
| Analysis of Drosophila p8 and p52 mutants reveals distinct roles for the maintenance of TFIIH stability and male germ cell differentiation G Cruz-Becerra, M Juárez, V Valadez-Graham, M Zurita Open biology 6 (10), 160222, 2016 | 7 | 2016 |
| In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells A Schcolnik-Cabrera, M Juárez, B Oldak, M Cruz-Rivera, A Flisser, ... Archives of medical research 51 (1), 65-75, 2020 | 6 | 2020 |
| Evaluation of ivermectin as an antitumoural drug M Juarez, A Chavez, A Duenas CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 505-505, 2017 | | 2017 |
